- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03606772
Gynecological Presentations Following Supracervical Hysterectomy (GPH)
June 9, 2019 updated by: Ayman S Dawood, MD, Tanta University
Gynecological Presentations and Pelvic Symptoms Following Supracervical Hysterectomy for Benign Pathologies: A Survey Study
Supracervical hysterectomy is widely common and had many complications either immediate or delayed.
In these patients bleeding, infection, chronic pelvic pain are common.
In these patients cervical biopsy will be done and histopathological examinations will be done to evaluate the pathology in these patients.
Study Overview
Detailed Description
- Study design and settings: Cross sectional descriptive studies
- Patients: 130 patients with hysterectomy recruited at Tanta University Hospital, gynecology clinics in central hospitals in Gharbia governorate will be recruited according inclusion and exclusion criteria. Inclusion criteria include all symptomatizing patients following supracervical hysterectomy, of any age, of any complaints. The
- Methods: All patients' demographic data, history, indication of hysterectomy, duration since operation, postoperative complications and their main complaint.
Study Type
Observational
Enrollment (Actual)
130
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Algharbia
-
Tanta, Algharbia, Egypt, 31111
- Ayman Shehata Dawood
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
• Patients: 1280 patients with hysterectomy recruited at Tanta University Hospital, gynecology clinics in central hospitals in Gharbia governorate
Description
Inclusion Criteria:
- Hysterectomy for benign pathologies
Exclusion Criteria:
- Hysterectomy for malignancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
supracervical hysterectomy
Patients operated abdominal by removal of uterus, with removal of tubes and ovaries and retaining of cervix
|
Filling printed questionnaire + Pelvic examination
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
number of participant with gynecological symptoms following hysterectomy
Time Frame: 6 months
|
Symptoms occurring after hysterectomy
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ayman Dawood, Lecturer at Tanta University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2018
Primary Completion (Actual)
March 31, 2019
Study Completion (Actual)
March 31, 2019
Study Registration Dates
First Submitted
July 22, 2018
First Submitted That Met QC Criteria
July 27, 2018
First Posted (Actual)
July 31, 2018
Study Record Updates
Last Update Posted (Actual)
June 12, 2019
Last Update Submitted That Met QC Criteria
June 9, 2019
Last Verified
June 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- GPHysterectomy
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Patients data are not allowed to be public
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gynecological Survey
-
Boston Children's HospitalDayton Children's Hospital; GetWellNetworkTerminatedInpatient Experience Survey Administration | Inpatient Experience Survey ResponseUnited States
-
Laval UniversityCompleted
-
Our Lady of Lourdes Hospital, DroghedaUnknown
-
Moens MaartenVrije Universiteit BrusselRecruitingSurvey | Neuromodulation | RegistryGermany
-
University of Alabama at BirminghamWithdrawn
-
Eskisehir Osmangazi UniversityRecruiting
-
University Hospital, Basel, SwitzerlandCompleted
-
Universitair Ziekenhuis BrusselCompleted
-
Zonguldak Bulent Ecevit UniversityCompleteda Survey-based StudyTurkey
-
Universitair Ziekenhuis BrusselCompleted